Press release Read more about argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
Press release Read more about Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 20 June 2024
Press release Read more about Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024
Press release Read more about PR Orange: Transactions carried out as part of a share buyback program and outside of a liquidity contract
Press release Read more about Panoro Energy ASA - Announces Transactions Made Under the Company's Share Buyback Program
Press release Read more about BioSenic signs a new subscription agreement for a maximum of EUR 2.1M in convertible bonds